USO - US Oncology Research Network

Clinical research site in Nashville, Tennessee

Part of US Oncology

As of July 2026, 2 paid clinical trials are recruiting at USO - US Oncology Research Network in Nashville, Tennessee. Active studies at this site cover conditions such as Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis and Pancreatic Ductal Adenocarcinoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at USO - US Oncology Research Network (2)

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for Carcinoma, Non-Small-Cell Lung

88 locations incl. Huntsville

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06119581·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

for Pancreatic Ductal Adenocarcinoma

25 locations incl. Duarte

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06586515·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

More research sites in Nashville

Vanderbilt University Medical Center (369 trials)
SCRI Oncology Partners (127 trials)
Vanderbilt University/Ingram Cancer Center (86 trials)
Sarah Cannon Research Institute (62 trials)
Vanderbilt University (55 trials)
Tennessee Oncology (48 trials)
Vanderbilt-Ingram Cancer Center (39 trials)
The Children's Hospital at TriStar Centennial (28 trials)
Monroe Carell Jr. Children's Hospital at Vanderbilt (13 trials)
Tennessee Oncology, PLLC (13 trials)

Explore more

Paid clinical trials in Nashville, TN · Tennessee clinical trials